Business Context and Reporting Period
Company: Prospect Capital Corporation (PSEC)
Filing Type: Form 8-K (Current Report)
Date of Report: July 7, 2026
Event: Special Meeting of Stockholders held virtually on July 7, 2026, to vote on a specific corporate proposal.
Key Financial Metrics
This filing is a current report regarding a stockholder vote and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
The primary material event reported is the approval of a proposal to renew the Company's authorization to sell shares of common stock below its then-current net asset value (NAV) per share for the next 12 months, subject to specific conditions (including a limit that sales on any given date do not exceed 25% of outstanding common stock).
Voting Statistics
- Total Shares Eligible to Vote: 556,508,215 (as of March 11, 2026 record date).
- Affiliate Shares: 134,072,811.
- Proposal 1 Results (Total):
- For: 277,640,199
- Against: 63,873,735
- Abstained: 7,460,523
- Broker Non-Votes: 0
- Proposal 1 Results (Adjusted for Affiliates):
- For: 145,994,733
- Against: 63,873,735
- Abstained: 7,460,523
The proposal was approved by the stockholders.
Guidance, Outlook, and Risks
This filing does not contain management guidance, financial outlook, or specific risk factors beyond the context of the authorized share sales. The filing references a definitive proxy statement filed on March 11, 2026, for detailed conditions regarding the share sales.
Investor Verification Checklist
- Verify the specific conditions and limitations for the below-NAV share sales in the definitive proxy statement filed on March 11, 2026.
- Confirm the current Net Asset Value (NAV) per share to assess the potential dilution impact of the authorized sales.
- Review the Company's most recent 10-Q or 10-K for actual financial performance metrics, as this 8-K contains no financial data.
- Monitor future 8-K filings for the execution of share sales under the newly renewed authorization.